Arcus Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,453
| Closed | -$723K | – | 133 |
|
|
2025
Q1 | $723K | Buy |
+1,453
| New | +$723K | 0.29% | 59 |
|
|
2024
Q1 | – | Sell |
-1,093
| Closed | -$580K | – | 120 |
|
|
2023
Q4 | $580K | Buy |
+1,093
| New | +$580K | 0.2% | 59 |
|
|
2023
Q3 | – | Sell |
-1,429
| Closed | -$746K | – | 133 |
|
|
2023
Q2 | $746K | Hold |
1,429
| – | – | 0.22% | 50 |
|
|
2023
Q1 | $824K | Buy |
1,429
+611
| +75% | +$352K | 0.28% | 46 |
|
|
2022
Q4 | $451K | Sell |
818
-1,325
| -62% | -$730K | 0.18% | 57 |
|
|
2022
Q3 | $1.09M | Buy |
2,143
+694
| +48% | +$352K | 0.45% | 37 |
|
|
2022
Q2 | $787K | Sell |
1,449
-7
| -0.5% | -$3.8K | 0.34% | 43 |
|
|
2022
Q1 | $860K | Sell |
1,456
-6
| -0.4% | -$3.54K | 0.31% | 44 |
|
|
2021
Q4 | $976K | Buy |
1,462
+665
| +83% | +$444K | 0.33% | 38 |
|
|
2021
Q3 | $455K | Buy |
+797
| New | +$455K | 0.17% | 59 |
|